Immunotherapy: What lies beyond - 01/03/14
| Disclosure of potential conflict of interest: T. B. Casale has received consultancy fees from Stallergenes, Merck, Cirassia, and Cytos; is the American Academy of Allergy, Asthma & Immunology Executive Vice President; has received research support from Merck, Stallergenes, ALK-Abelló, Circassia, and Cytos; and has received lecture fees from ALK-Abelló. J. R. Stokes declares that he has no relevant conflicts of interest. |
Vol 133 - N° 3
P. 620 - mars 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
